United States · Bill · HR
H.R. 7616 (96th)
A bill to establish a national center for clinical pharmacology in the Department of Health and Human Services.
Introduced
18 June 1980
Last action
—
Status
Referred to House Committee on Interstate and Foreign Commerce.
Sponsors
—
Subjects
Discovery layer
Source updated
5 February 2024
Summary
Establishes within the Department of Health and Human Services the National Center for Clinical Pharmacology under a Director appointed by the Secretary. Authorizes the Center to conduct and support research in clinical pharmacology and clinical pharmacy. Requires the Center to conduct an ongoing review and analysis of the use of drug products in the United States. Requires the Center to prepare an annual Drug Experience Assessment Report for the Secretary. Directs the Center to facilitate analysis of the consequences of State and Federal regulation of the manufacture, importation, exportation, and distribution of drug products, research activities and practices, and the practices of the pharmaceutical industry and health professionals respecting drug products. Requires the Director to periodically report to the Secretary on new techniques in research, areas where current research is insufficient, and promising new drugs in foreign countries.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Introduced in House
summary · EN · 18 June 1980
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/96th-congress/house-bill/7616
- Open data entity: https://api.congress.gov/v3/bill/96/hr/7616